IL10 and colitis: Moreover, the increasing ratio of Bacteroidetes to Firmicutes has been associated with improved colitis outcomes in mice models (Li et al. 2022), and administration of EcN-TNFαNb and EcN-IL10 combination significantly augmented the ratio of Bacteroidetes to Firmicutes, which had been reduced due to DSS treatment.